De-risking the clinical development of cholesteryl ester transfer protein inhibitors: how much is good enough?

Benoit J. Arsenault, S. Matthijs Boekholdt, Jean-Claude Tardif, John J. P. Kastelein

Research output: Contribution to journal › Editorial › Academic › peer-review

8 Citations (Scopus)

Access to Document

@article{0caca11cefa948a78958a852e5c8ac3d,

title = "De-risking the clinical development of cholesteryl ester transfer protein inhibitors: how much is good enough?",

author = "Arsenault, {Benoit J.} and Boekholdt, {S. Matthijs} and Jean-Claude Tardif and Kastelein, {John J. P.}",

year = "2012",

doi = "https://doi.org/10.1093/eurheartj/ehr408",

language = "English",

volume = "33",

pages = "1548--1550",

journal = "European Heart journal",

issn = "0195-668X",